October 2009 - 3-D Stem Cell Culture Bioreactor Synthecon, Inc has introduced the Rotary Cell Culture SystemTM for Stem Cell culture. This 3-D cell culture bioreactor is capable of expanding/differentiating Embryonic Stem Cells, Cord Blood Stem Cells and Bone marrow Stem Cells. [read more]

October 2009 - RCCS-8DQ Re-Define 3-dimensional Cell Culture with Synthecon’s Rotary Cell Culture Systems (RCCS)Drug Screening, Tumor Modeling, Tissue Engineering, Infectious Disease Modeling, Stem Cell Expansion/Differentiation and many more applications. [read more]

October 2009 - RCCSTM Bioreactors to study Hepatitis C infection in-vitroIn a recent study conducted by scientists at the University of Illinois, Chicago, Synthecon, Inc. Rotary Cell Culture SystemTM was used to construct a Huh 7 3-D cell culture model (human hepatoma-derived cell line) that was superior to conventional 2-D monolayers in terms of increased hepatocyte-specific gene expression and cellular polarity. [read more]

May 18, 2007 Synthecon Issued Patent For A Dual Cell Culture Chamber Rotary Bioreactor System Needed for Development Of Stem Cell Therapeutic Applications [ read more ]

Dec 2005 Synthecon Selected to Present At The Prestigious Levine Symposium On Diabetes [ read more ]

Dec 2005 News Release From UTMB Identifies Synthecon Bioreactor As Key Link That May Substantially Speed Development of Stem Cell Treatments For Life-threatening Illnesses [ read more ]

Nov 2005 Synthecon Inc. Recognized As One of Houston’s “Fast Tech Fifty” Companies [ read more ]

Nov 2003 Synthecon Inc. Recognized As One of Houston's "Fast Tech 50" Companies [ read more ]

May 2003 Synthecon Appoints William J. Anderson President & CEO [ read more ]

June 11, 2001 NASA/SYNTHECON Protein Pharmaceutical License

Jan. 17, 2001 New bioreactor added to the Synthecon product line

March 2, 2000 Texas Selects Synthecon to Represent State at BIO 2000